Evidence map›Paper›PMID 21356420›Full record

ReviewPrimary care2011

Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Daniel Ciccarone

Abstract readReview
In one paragraph

Review in Primary care, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 3 syntheses or guidelines pooled it, 202 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2015
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Housing Instability Associated with Return to Stimulant Use among Previously Abstaining Women.International journal of environmental research and public health · 2023
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Daniel CiccaroneDepartment of Family and Community Medicine, University of California San Francisco, 500 Parnassus Avenue, MU-3E, Box 0900, San Francisco, CA 94143-0900, USA. Electronic address: ciccaron@fcm.ucsf.edu.
University of California, San Francisco · US

Funding

Heroin Price, Purity and Outcomes StudyR01DA027599 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CICCARONE, DANIEL H · 2010 to 2014
$1.8M
The Medical Consequences of Different Types of HeroinK23DA016165 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CICCARONE, DANIEL H · 2004 to 2008
$825k
NIDA NIH HHS DA16165NIDA NIH HHS K23 DA016165NIDA NIH HHS R01 DA027599
6 · The paper itself

Abstract

The high prevalence of stimulant abuse and its harmful consequences make the screening, diagnosis, and referral for treatment of persons with stimulant abuse a top concern for primary care providers. Having a working knowledge of use patterns, clinical symptomatology, end-organ effects, and advances in treatment of stimulant abuse is essential. Although cocaine and amphetamine have different use patterns, duration of action, and so forth, the consequences of use are remarkably similar. Primary care is at the forefront of screening, brief risk reduction interventions, and diagnosis of medical sequelae, with referral to addiction specialist treatment when necessary.

Indexed as

AmphetamineAmphetamine-Related DisordersCentral Nervous System StimulantsCocaineCocaine-Related DisordersDopamine Uptake InhibitorsHIV InfectionsHumansMethamphetaminePrimary Health CareSubstance-Related DisordersUnited StatesAmphetamineCentral Nervous System StimulantsCocaineDopamine Uptake InhibitorsMethamphetamine

Identifiers

PMID21356420
PMCPMC3056348
OpenAlexW2154960645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.